
Please try another search
Investors in Vical Incorporated (NASDAQ:VICL) need to pay close attention to the stock based on moves in the options market lately. That is because the Sep 20, 2019 $1.00 Call had some of the...
Vical Incorporated (NASDAQ:VICL) and partner Astellas Pharma, Inc. (OTC:ALPMY) announced disappointing top-line data from a phase II study on their experimental cytomegalovirus (CMV) vaccine...
Vical Incorporated (NASDAQ:VICL) presented data from a phase I/II study on its genital herpes vaccine at a meeting of the American Society for Microbiology. The randomized, double-blind, placebo...
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review